Come for EUROGIN 2022
0
2022-04-11
From April 10 to 12, 2022, the European Research Organization on Genital Infection and Neoplasia (EUROGIN 2022) was held in Düsseldorf, Germany. Although the COVID-19 epidemic has not subsided, it has attracted many of the world's top cervical cancer and HPV-related experts to conduct open discussion meetings offline and face-to-face.
At the meeting, the experts intensely discussed the ambitious goal of eliminating cervical cancer worldwide, and all agreed to make efforts to expand HPV screening coverage in all regions worldwide. Countries should quickly resume HPV screening and vaccination efforts due to COVID-19 and develop and implement plans. Regardless of the economy, the next 1-2 years will be more necessary than ever to conduct relevant clinical studies and identify more cost-effective ways to expand HPV screening coverage, optimize screening programs, and develop practical diagnostic strategies for all regions.
For the first time, YanengBIO participated in EUROGIN, working with Swedish partners at the forefront to discuss with experts how to conduct cervical cancer screening more efficiently and cost-effectively. At the meeting, many experts from all over the world expressed their appreciation for the efforts made by YanengBIO in China's national cervical cancer elimination project in the past 20 years and they affirmed our cervical cancer screening series products.
We look forward to working together in the future to realize the wish at an early date: a wonderful world where cervical cancer and HPV-related malignant tumors are eliminated.
